Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel-Reference-Cited by-同舟云学术

Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel

Published:2017-02-09 Issue:7 Volume:57 Page:823-829
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Maggio Nicola¹²,Firer Maria³,Zaid Huda³,Bederovsky Yana³,Aboukaoud Mohammed³,Gandelman-Marton Revital²⁴,Noyman Iris⁵,Ekstein Dana⁶,Blatt Ilan¹²,Marom Eli⁷,Schwartzberg Eyal⁷,Israel Shoshana⁸,Ingber Arieh⁹,Brautbar Chaim⁸,Eyal Sara³

Affiliation:

1. Department of Neurology; Sheba Medical Center; Tel Hashomer Israel

2. Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv Israel

3. Institute for Drug Research, School of Pharmacy; The Hebrew University of Jerusalem; Jerusalem Israel

4. Department of Neurology; Assaf Harofeh Medical Center; Zerifin Israel

5. Department of Pediatric Neurology; Soroka Medical Center, Ben Gurion University of the Negev; Beer Sheva Israel

6. Department of Neurology; Agnes Ginges Center for Human Neurogenetics; Hadassah-Hebrew University Medical Center; Jerusalem Israel

7. Pharmaceutical Division; Israel Ministry of Health; Jerusalem Israel

8. Tissue Typing Unit; Hadassah-Hebrew University Medical Center; Jerusalem Israel

9. Department of Dermatology; Hadassah-Hebrew University Medical Center; Jerusalem Israel

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference37 articles.

1. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study;Auquier-Dunant;Arch Dermatol,2002

2. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR study;Mockenhaupt;J Invest Dermatol,2008

3. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis;Roujeau;N Engl J Med,1995

4. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis;Sassolas;Clin Pharmacol Ther,2010

5. Lamotrigine-associated rash: risk/benefit considerations in adults and children;Guberman;Epilepsia,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methods for identifying culprit drugs in cutaneous drug eruptions: A scoping review;2021-05-14

2. Toxic Epidermal Necrolysis (TEN)/Stevens-Johnson Syndrome (SJS) Epidemiology and Mortality Rate at King Fahad Specialist Hospital (KFSH) in Qassim Region of Saudi Arabia: A Retrospective Study;Dermatology Research and Practice;2020-10-09

3. Aetiopathogenesis of severe cutaneous adverse reactions (SCARs) in children: A 9‐year experience in a tertiary care paediatric hospital setting;Clinical & Experimental Allergy;2019-10-28

4. Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations;Pharmaceutical Research;2018-09-17

5. Stevens-Johnson syndrome/toxic epidermal necrolysis in Jewish and Arab populations;Epilepsia;2018-07